Hitzenbichler F, Mohr A, Camboni D, Simon M, et al. Dalbavancin as long-term suppressive therapy for patients with Gram-positive bacteremia due to an intravascular source-a series of four cases. Infection 2021;49:181-186.
PMID: 32965641